Targeting ECM components or their regulatory pathways is a promising therapeutic approach. Inhibitors of MMPs, agents that modulate collagen synthesis, and treatments aimed at reducing fibrosis are being explored. Understanding ECM changes can lead to the development of novel therapies for various diseases.
